Indeed, a combination therapy of capsaicin analogues with PPARɣ agonists, such as thiazolidinediones, is a promising strategy for the treatment of several cancer cell lines (Hurley et al. 2017; Szoka and Palka 2020). This evidence concerns the gene PPARA and cancer.